Balco Medical Centre, Raipur – India
About Dr. Bhawna Sirohi
Dr. Bhawna Sirohi is a globally recognized medical oncologist with expertise in treating gastrointestinal and breast cancers. Trained in both India and the UK, she is known for her evidence-based, patient-focused approach, emphasizing early diagnosis, survivorship, and access to quality care. Dr. Sirohi has held leadership roles at top oncology centers and actively contributes to global oncology standards through organizations like Lancet Oncology and ASCO. Her areas of focus include chemotherapy, immunotherapy, and targeted therapy. Widely respected for her compassionate care, she is also an advocate for health equity and innovation in cancer management.
- MBBS – LLRM Medical College, Meerut, India
- DCH (Diploma in Child Health) – LLRM Medical College, Meerut, India
- Medical Oncology Training – Tata Memorial Centre, Mumbai, India
- Specialist Training (CCT) in Medical Oncology – UK
- Fellowship – Royal College of Physicians (FRCP), London
Major Cancer Types Treated:
- Breast Cancer
- Colorectal Cancer
- Pancreatic and Gallbladder Cancer
- Neuroendocrine Tumors
- Stomach Cancer
- Liver (Hepatocellular) Cancer
- Personalised Cancer Therapy
- Cancer Survivorship Programs
- Early Detection and Cancer Prevention
- Global Oncology and Health Equity Initiatives
- Gastrointestinal Oncology
- Breast Oncology
- Advanced Chemotherapy Protocols
- Hormonal Therapy
- Targeted Therapy
- Immunotherapy Approaches
- Survivorship Planning and Financial Counseling
- Medical Director & Senior Medical Oncologist, BALCO Medical Centre, Raipur (Current)
- Lead Medical Oncologist, Apollo Proton Cancer Centre, Chennai
- Director of Medical Oncology, Max Cancer Centre, New Delhi
- Head of Medical Oncology, Artemis Cancer Centre, Gurgaon
- Consultant Medical Oncologist, Tata Memorial Centre, Mumbai
- Consultant Oncologist, Royal Marsden NHS Foundation Trust, London
- Consultant, Addenbrookes NHS Trust and Barts Health NHS Trust, UK
- President, Oncology Section, Royal Society of Medicine, UK (2018–2019)
- Honorary Consultant, Queen Mary University, London (2018–2021)
- Member, Lancet Oncology International Advisory Board
- Founder President, New India Cancer Charity Initiative (NICCI)
- Contributing member of ASCO Committees on health equity, climate change, and outcomes research
Published Papers and Articles: Authored over 200 research publications in national and international oncology journals.A few are mentioned below:
- Anu, R. I., Patel, A., Pathak, N., Mehta, P., Chougule, A., Sheth, H., … & Kulkarni, P. (2025). Uniform Reporting of Next Generation Sequencing: Indian Society of Medical and Pediatric Oncology. Indian Journal of Medical and Paediatric Oncology.
- Varshney, P., Baghmar, S., Sirohi, B., Abou-Alfa, G. K., Cao, H. T., Sharma, L. M., … & Kapoor, V. K. (2025). Neoadjuvant treatment for incidental gallbladder cancer: A systematic review. Annals of Hepato-Biliary-Pancreatic Surgery, 29(2), 113.
- Bajpai, J., Gandhi, S. S., Rajappa, S., Pathak, R., Joshi, S., Batra, A., … & Aggrawal, S. (2024). Indian Society of Medical and Paediatric Oncology (ISMPO)—Breast Cancer in Young Guidelines. Indian Journal of Medical and Paediatric Oncology.
- Palepu, J., Endo, I., Chaudhari, V. A., Murthy, G. V. S., Chaudhuri, S., Adam, R., … & Jarnagin, W. (2024). ‘IHPBA-APHPBA clinical practice guidelines’: international Delphi consensus recommendations for gallbladder cancer. HPB, 26(11), 1311-1326.
International patients seeking consultation, treatment or second opinion from Dr. Bhawna Sirohi can contact Cancer Rounds team for the following:
- Language Support
- Visa & Travel Assistance
- Pre-treatment Virtual Consultations
Patients highlight her empathetic communication, evidence-based treatments, and global expertise.“Dr. Sirohi’s approach was both professional and compassionate. She took the time to explain every aspect of my treatment, making me feel involved and informed throughout the process.” – A. Singh“Her dedication to patient care is evident in every interaction. I felt genuinely cared for, not just as a patient, but as a person.” – S. Sen“Dr. Bhawna Sirohi is among the best GI cancer surgeons in India.” – T. Kumar
Patient-Centered Care:
Dr. Sirohi believes in personalised, patient-centric oncology where treatment decisions are made collaboratively with patients, respecting their values and preferences.Technology & Innovation:
She actively promotes early detection initiatives, survivorship planning, and integration of global best practices, advocating for judicious use of advanced therapies to reduce treatment burden.Consultation Fees & Treatment CostsTreatment Costs (Indicative Range):
Note: These are estimated costs. Contact Cancer Rounds team for personalised treatment plan and its cost.
| Treatment Type | Estimated Cost (INR) | Estimated Cost (USD) |
| Chemotherapy Cycle | ₹30,000 – ₹80,000 | $400 – $1,100 |
| Targeted Therapy | ₹1,00,000 – ₹3,00,000 | $1,300 – $4,000 |
| Immunotherapy Cycle | ₹1,50,000 – ₹4,00,000 | $2,000 – $5,300 |
| Hormonal Therapy | ₹20,000 – ₹50,000 | $260 – $660 |
Frequently Asked Questions
You can contact the Cancer Rounds team to schedule an appointment with Dr. Bhawna Sirohi.
Yes, virtual consultations are available for both domestic and international patients.
Patients should share medical records, histopathology reports, imaging studies (CT, MRI, PET-CT), and previous treatment summaries.
Dr. Sirohi advocates early diagnosis, tailored therapy based on tumor biology, and focuses strongly on survivorship care post-treatment.
